Description
Tenofovir
Each film-coated tablet contains Tenofovir alafenamide fumarate 28 mg equivalent to Tenofovir alafenamide … 25mg.
INDICATIONS
LuciTeno is a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor and is indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 6 years of age and older and weighing at least 25 kg with compensated liver disease.
DOSAGE AND USE
• Recommended dosage: 25 mg (one tablet) taken orally once daily with food. • Renal Impairment: LuciTeno is not recommended in patients with estimated creatinine clearance below 15 mL per minute who are not receiving chronic hemodialysis. In patients on chronic hemodialysis, on hemodialysis days, administer LuciTeno after hemodialysis. • Hepatic Impairment: LuciTeno is not recommended in patients with decompensated (Child-Pugh B or C) hepatic impairment.
STORAGE
In a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY
LUCIUS PHARMACEUTICALS(LAO) CO., LTD. No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNINGS
Keep medicine out of reach of Children. Do not administer LuciTeno during Pregnancy and Lactation.
Reviews
There are no reviews yet.